开云app官网登录入口网页版-官方正版

#阻滞剂#

205篇内容 | 2882人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2085873, encodeId=64c320858e3c8, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Hypertension：血管紧张素受体阻滞剂与较低的从轻度认知障碍进展到痴呆风险相关, objectType=article, longId=731475, objectId=b7f1e31475dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7f1e31475dd, replyNumber=0, likeNumber=99, createdTime=2022-12-06, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7f1e31475dd, moduleTitle=Hypertension：血管紧张素受体阻滞剂与较低的从轻度认知障碍进展到痴呆风险相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b7f1e31475dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085876, encodeId=5a4020858e61d, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=ESC 2022：ARB和β 受体阻滞剂可能推迟马凡综合征患者需要手术的时间（MTT研究）, objectType=article, longId=737370, objectId=b7a5e373708e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7a5e373708e, replyNumber=0, likeNumber=83, createdTime=2023-04-21, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7a5e373708e, moduleTitle=ESC 2022：ARB和β 受体阻滞剂可能推迟马凡综合征患者需要手术的时间（MTT研究）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b7a5e373708e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085875, encodeId=272420858e5d2, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=STROKE：β受体阻滞剂可以降低脑海绵状血管畸形患者颅内出血或持续性/进行性局灶性神经功能缺损的风险, objectType=article, longId=734037, objectId=6c11e3403793, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c11e3403793, replyNumber=0, likeNumber=90, createdTime=2022-12-08, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c11e3403793, moduleTitle=STROKE：β受体阻滞剂可以降低脑海绵状血管畸形患者颅内出血或持续性/进行性局灶性神经功能缺损的风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6c11e3403793)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085869, encodeId=caef208586908, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA Cardiol：多形性室速患者服用β受体阻滞剂治疗的预后, objectType=article, longId=302267, objectId=b9db30226eb1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9db30226eb1, replyNumber=0, likeNumber=82, createdTime=2022-08-30, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9db30226eb1, moduleTitle=JAMA Cardiol：多形性室速患者服用β受体阻滞剂治疗的预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b9db30226eb1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085866, encodeId=5e80208586648, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JACC：停用β受体阻滞剂可改善心衰患者的运动能力, objectType=article, longId=220930, objectId=528e220930b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=528e220930b4, replyNumber=0, likeNumber=93, createdTime=2021-12-09, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=528e220930b4, moduleTitle=JACC：停用β受体阻滞剂可改善心衰患者的运动能力, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=528e220930b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085871, encodeId=88f920858e10f, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA Cardiol：儿茶酚胺敏感性室速患者采用β-受体阻滞剂治疗的预后, objectType=article, longId=726040, objectId=7776e260404a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7776e260404a, replyNumber=0, likeNumber=92, createdTime=2022-05-12, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7776e260404a, moduleTitle=JAMA Cardiol：儿茶酚胺敏感性室速患者采用β-受体阻滞剂治疗的预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7776e260404a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085874, encodeId=129a20858e489, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=J Gastroenterology：钙通道阻滞剂可以改善肝内胆管癌切除术后患者的预后, objectType=article, longId=733169, objectId=550ce33169d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=550ce33169d4, replyNumber=0, likeNumber=80, createdTime=2023-01-12, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=550ce33169d4, moduleTitle=J Gastroenterology：钙通道阻滞剂可以改善肝内胆管癌切除术后患者的预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=550ce33169d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085872, encodeId=5d6620858e2a7, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=AP&T: 新型钾竞争性酸阻滞剂克维拉赞(keverprazan)治疗糜烂性食管炎的疗效和安全性分析, objectType=article, longId=728067, objectId=b454e280675c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b454e280675c, replyNumber=0, likeNumber=89, createdTime=2022-06-28, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b454e280675c, moduleTitle=AP&T: 新型钾竞争性酸阻滞剂克维拉赞(keverprazan)治疗糜烂性食管炎的疗效和安全性分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b454e280675c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085870, encodeId=b85d20858e029, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Stroke：β受体阻滞剂或他汀类药物使用与海绵状畸形出血风险之间的关系, objectType=article, longId=724173, objectId=af7ee2417375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af7ee2417375, replyNumber=0, likeNumber=99, createdTime=2022-04-28, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af7ee2417375, moduleTitle=Stroke：β受体阻滞剂或他汀类药物使用与海绵状畸形出血风险之间的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=af7ee2417375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085859, encodeId=4053208585931, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Clin Gastroenterology H：非选择性β受体阻滞剂治疗后血管性血友病因子水平降低表明治疗效果良好, objectType=article, longId=214231, objectId=3b8421423128, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b8421423128, replyNumber=0, likeNumber=0, createdTime=2022-05-05, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b8421423128, moduleTitle=Clin Gastroenterology H：非选择性β受体阻滞剂治疗后血管性血友病因子水平降低表明治疗效果良好, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3b8421423128)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085864, encodeId=b9b920858642e, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=围手术期β受体阻滞剂的应用, objectType=article, longId=219779, objectId=0a36219e79fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a36219e79fa, replyNumber=0, likeNumber=93, createdTime=2022-08-28, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a36219e79fa, moduleTitle=围手术期β受体阻滞剂的应用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0a36219e79fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085863, encodeId=7436208586328, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JEADV:接受β受体阻滞剂治疗的高血压患者新发银屑病的风险研究, objectType=article, longId=219033, objectId=64d521903390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64d521903390, replyNumber=0, likeNumber=0, createdTime=2022-10-05, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64d521903390, moduleTitle=JEADV:接受β受体阻滞剂治疗的高血压患者新发银屑病的风险研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=64d521903390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085868, encodeId=91cf208586891, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Mayo Clin Proc：成人慢性阻塞性肺疾病心肌梗死后心脏选择性与非选择性β受体阻滞剂的比较, objectType=article, longId=300307, objectId=bf2730030e4f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf2730030e4f, replyNumber=0, likeNumber=84, createdTime=2022-08-13, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf2730030e4f, moduleTitle=Mayo Clin Proc：成人慢性阻塞性肺疾病心肌梗死后心脏选择性与非选择性β受体阻滞剂的比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bf2730030e4f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085861, encodeId=a54320858618b, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=GUT：β受体阻滞剂通过改善晚期慢性肝病患者全身炎症从而改善临床结果, objectType=article, longId=216275, objectId=869f2162e50f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=869f2162e50f, replyNumber=0, likeNumber=87, createdTime=2021-10-21, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=869f2162e50f, moduleTitle=GUT：β受体阻滞剂通过改善晚期慢性肝病患者全身炎症从而改善临床结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=869f2162e50f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085862, encodeId=ef792085862d2, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=AJG：钾离子竞争性酸阻滞剂-沃诺拉赞会比普通质子泵抑制剂更容易导致艰难梭菌感染吗？, objectType=article, longId=216572, objectId=c1772165e2c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1772165e2c0, replyNumber=0, likeNumber=84, createdTime=2022-02-04, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1772165e2c0, moduleTitle=AJG：钾离子竞争性酸阻滞剂-沃诺拉赞会比普通质子泵抑制剂更容易导致艰难梭菌感染吗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c1772165e2c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085867, encodeId=2500208586eef, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=美托洛尔、比索洛尔、阿替洛尔…… β 受体阻滞剂全面总结！, objectType=article, longId=293850, objectId=cb88293850dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb88293850dd, replyNumber=0, likeNumber=86, createdTime=2022-07-30, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb88293850dd, moduleTitle=美托洛尔、比索洛尔、阿替洛尔…… β 受体阻滞剂全面总结！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cb88293850dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085865, encodeId=c82e20858652b, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Clinical Infectious Disease: 高血压和使用钙通道阻滞剂对结核病治疗结果的影响, objectType=article, longId=219951, objectId=2708219951ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2708219951ef, replyNumber=0, likeNumber=101, createdTime=2021-12-26, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2708219951ef, moduleTitle=Clinical Infectious Disease: 高血压和使用钙通道阻滞剂对结核病治疗结果的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2708219951ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085850, encodeId=8278208585072, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗, objectType=article, longId=205454, objectId=6ca6205454ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ca6205454ce, replyNumber=0, likeNumber=0, createdTime=2021-03-18, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ca6205454ce, moduleTitle=NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6ca6205454ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085856, encodeId=05af2085856fa, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAHA：改善的扩张型心肌病患者β受体阻滞剂与左心室重构之间的相关性分析, objectType=article, longId=212143, objectId=aa2321214362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa2321214362, replyNumber=0, likeNumber=83, createdTime=2021-10-12, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa2321214362, moduleTitle=JAHA：改善的扩张型心肌病患者β受体阻滞剂与左心室重构之间的相关性分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=aa2321214362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085860, encodeId=866f2085860e2, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Crit Care：β受体阻滞剂对心源性休克患者正性肌力反应和临床结局的影响, objectType=article, longId=215595, objectId=9c3a21559504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c3a21559504, replyNumber=0, likeNumber=87, createdTime=2022-01-01, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c3a21559504, moduleTitle=Crit Care：β受体阻滞剂对心源性休克患者正性肌力反应和临床结局的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9c3a21559504)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

阻滞剂

2020-05-29

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Hypertension：血管紧张素受体阻滞剂与较低的从轻度认知障碍进展到痴呆风险相关

2022-12-06

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

ESC 2022：ARB和β 受体阻滞剂可能推迟马凡综合征患者需要手术的时间（MTT研究）

2023-04-21

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

STROKE：β受体阻滞剂可以降低脑海绵状血管畸形患者颅内出血或持续性/进行性局灶性神经功能缺损的风险

2022-12-08

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA Cardiol：多形性室速患者服用β受体阻滞剂治疗的预后

2022-08-30

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JACC：停用β受体阻滞剂可改善心衰患者的运动能力

2021-12-09

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA Cardiol：儿茶酚胺敏感性室速患者采用β-受体阻滞剂治疗的预后

2022-05-12

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

J Gastroenterology：钙通道阻滞剂可以改善肝内胆管癌切除术后患者的预后

2023-01-12

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

AP&T: 新型钾竞争性酸阻滞剂克维拉赞(keverprazan)治疗糜烂性食管炎的疗效和安全性分析

2022-06-28

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Stroke：β受体阻滞剂或他汀类药物使用与海绵状畸形出血风险之间的关系

2022-04-28

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Clin Gastroenterology H：非选择性β受体阻滞剂治疗后血管性血友病因子水平降低表明治疗效果良好

2022-05-05

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

围手术期β受体阻滞剂的应用

2022-08-28

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JEADV:接受β受体阻滞剂治疗的高血压患者新发银屑病的风险研究

2022-10-05

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Mayo Clin Proc：成人慢性阻塞性肺疾病心肌梗死后心脏选择性与非选择性β受体阻滞剂的比较

2022-08-13

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

GUT：β受体阻滞剂通过改善晚期慢性肝病患者全身炎症从而改善临床结果

2021-10-21

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

AJG：钾离子竞争性酸阻滞剂-沃诺拉赞会比普通质子泵抑制剂更容易导致艰难梭菌感染吗？

2022-02-04

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

美托洛尔、比索洛尔、阿替洛尔…… β 受体阻滞剂全面总结！

2022-07-30

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Clinical Infectious Disease: 高血压和使用钙通道阻滞剂对结核病治疗结果的影响

2021-12-26

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗

2021-03-18

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAHA：改善的扩张型心肌病患者β受体阻滞剂与左心室重构之间的相关性分析

2021-10-12

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Crit Care：β受体阻滞剂对心源性休克患者正性肌力反应和临床结局的影响

2022-01-01

科室
- - 订阅+
  - 更多科室
工具
服务